Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Why are we not screening for anal cancer routinely - HIV physicians’ perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study

Authors: Jason J Ong, Meredith Temple-Smith, Marcus Chen, Sandra Walker, Andrew Grulich, Jennifer Hoy, Christopher K Fairley

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Anal cancer is a priority health issue in HIV positive men who have sex with men. Anal cancer screening may be aimed at either detecting the precursor lesion (high grade anal intraepithelial neoplasia(HGAIN)) or early anal cancer. To date no qualitative study has explored the views of HIV physicians regarding anal cancer and its screening.

Methods

We conducted indepth interviews with 20 HIV physicians (Infectious diseases, Immunology, Sexual health, General practice) in different settings (hospital, sexual health centres, general practice) from around Australia. Framework analysis was used to identify themes.

Results

HIV physicians viewed anal cancer as a significant health issue and all agreed on the importance of anal cancer screening amongst HIV positive MSM if a valid screening method was available. Barriers for utilizing anal cytology was based primarily on the theme of insufficient evidence (e.g. no studies demonstrating reduction in mortality following screening or effective treatments for HGAIN). Barriers for utilizing DARE for early cancer detection were based on systemic factors (e.g. lack of opportunity, lack of priority, differences in HIV care practices); health provider factors (lack of evidence, difficulty discussing with patients, lack of confidence in DARE) and patient factors (perceived discomfort of DARE for patients, low anal cancer risk awareness). Physicians were willing to consider the idea of patient self-examination and partner-examination although concerns were raised regarding its reliability and issues surrounding partner dynamics.

Conclusions

HIV physicians remain ambivalent regarding the most effective means to screen for anal cancer. More research is needed to address the physicians’ concerns before anal cancer screening can be implemented into routine HIV care.
Literature
1.
Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317(16):973–7.CrossRefPubMed
2.
Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health. 2012;9(6):504–8.CrossRefPubMed
3.
Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22(10):1203–11.CrossRefPubMed
4.
D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2008;48(4):491–9.CrossRefPubMedPubMedCentral
5.
AIHW. Cancer incidence projections: Australia 2011 to 2020, Cancer series no 66. Canberra: Australian Institute of Health and Welfare; 2012.
6.
van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS. 2009;23(16):2183–90.CrossRefPubMedPubMedCentral
7.
Ong J, Chen M, Temple-Smith M, Walker S, Hoy J, Woolley I, et al. The inside story. Physicians’ views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men. J Med Screen. 2013;20(4):188–91.CrossRefPubMed
8.
Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5):755–63.CrossRefPubMed
9.
10.
Berry JM, Palefsky JM, Welton ML. Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am. 2004;13(2):355–73.CrossRefPubMed
11.
12.
Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer. 2004;101(2):281–8.CrossRefPubMed
13.
Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maisonet OG, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2008;51(1):73–81.CrossRefPubMed
14.
Mlakar B. Proctoscopy should be mandatory in men that have sex with men with external anogenital warts. Acta Dermatovenerol Alp Panonica Adriat. 2009;18(1):7–11.
15.
Pell C, Donohoe S, Conway D. Health Care Services for men who have sex with men in different Australian states and territories since the emergence of HIV. Sex Health. 2008;5(2):161–8.CrossRefPubMed
16.
17.
Ong J, Chen M, Grulich A, Fairley CW. Regional and national guideline recommendations for digital ano-rectal examination as a means for anal cancer screening in HIV positive men who have sex with men: a systematic review. BMC Cancer. 2014; accepted 5th July 2014.
18.
Rosswurm MA, Larrabee JH. A model for change to evidence-based practice. Image J Nurs Sch. 1999;31(4):317–22.CrossRefPubMed
19.
Kwong JJ, Cook P, Bradley-Springer L. Improving anal cancer screening in an ambulatory HIV clinic: experience from a quality improvement initiative. AIDS Patient Care STDS. 2011;25(2):73–8.CrossRefPubMed
20.
Kaczorowski J, Hearps SJ, Lohfeld L, Goeree R, Donald F, Burgess K, et al. Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Can Fam Physician. 2013;59(6):e282–9.PubMedPubMedCentral
21.
22.
Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–207. quiz CE201-204.
23.
Read T, Huson K, Millar J, Haydon A, Porter I, Grulich A, et al. Size of anal squamous cell carcinomas at diagnosis: a retrospective case series. Int J STD AIDS. 2013;24(11):879–82.CrossRefPubMed
24.
Augusto EF, Rosa ML, Cavalcanti SM, Oliveira LH. Barriers to cervical cancer screening in women attending the Family Medical Program in Niteroi, Rio de Janeiro. Arch Gynecol Obstet. 2013;287(1):53–8.CrossRefPubMed
25.
Hanson K, Montgomery P, Bakker D, Conlon M. Factors influencing mammography participation in Canada: an integrative review of the literature. Curr Oncol. 2009;16(5):65–75.PubMedPubMedCentral
26.
Ong J, Chen M, Temple-Smith MJ, Grulich A, Clarke P, Hoy J, et al. Baseline findings from the anal cancer examination(ACE) study – acceptability of digital ano-rectal examination as a means of screening for anal cancer in HIV positive men who have sex with men. Sex Transm Dis. 2014;41(S1):7.
27.
McCready T, Littlewood D, Jenkinson J. Breast self-examination and breast awareness: a literature review. J Clin Nurs. 2005;14(5):570–8.CrossRefPubMed
28.
Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130–51.CrossRefPubMed
29.
Moore RA, Topping A. Young men’s knowledge of testicular cancer and testicular self-examination: a lost opportunity? Eur J Cancer Care. 1999;8(3):137–42.CrossRef
Metadata
Title
Why are we not screening for anal cancer routinely - HIV physicians’ perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study
Authors
Jason J Ong
Meredith Temple-Smith
Marcus Chen
Sandra Walker
Andrew Grulich
Jennifer Hoy
Christopher K Fairley
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1430-1

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

A cross-sectional analysis of the relationship between tobacco and alcohol outlet density and neighbourhood deprivation

Research article

HIV and alcohol knowledge, self-perceived risk for HIV, and risky sexual behavior among young HIV-negative men identified as harmful or hazardous drinkers in Katutura, Namibia

Research article

Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012

Research article

Elevated neck circumference and associated factors in adolescents

Research article

Subjective health complaints in adolescent victims of cyber harassment: moderation through support from parents/friends - a Swedish population-based study

Research article

Performance of a five category front-of-pack labelling system – the 5-colour nutrition label – to differentiate nutritional quality of breakfast cereals in France